Advertisement
GH or MTD or NTRA
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GH’s FA Score shows that 0 FA rating(s) are green whileMTD’s FA Score has 2 green FA rating(s), and NTRA’s FA Score reflects 1 green FA rating(s).
- GH’s FA Score: 0 green, 5 red.
- MTD’s FA Score: 2 green, 3 red.
- NTRA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GH’s TA Score shows that 3 TA indicator(s) are bullish while MTD’s TA Score has 4 bullish TA indicator(s), and NTRA’s TA Score reflects 3 bullish TA indicator(s).
- GH’s TA Score: 3 bullish, 2 bearish.
- MTD’s TA Score: 4 bullish, 4 bearish.
- NTRA’s TA Score: 3 bullish, 5 bearish.
Price Growth
GH (@Medical Specialties) experienced а +8.57% price change this week, while MTD (@Medical Specialties) price change was -1.68% , and NTRA (@Medical Specialties) price fluctuated +7.13% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +5.67%. For the same industry, the average monthly price growth was +14.62%, and the average quarterly price growth was +35.84%.
Reported Earning Dates
GH is expected to report earnings on Oct 29, 2026.
MTD is expected to report earnings on Nov 05, 2026.
NTRA is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical Specialties (+5.67% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| GH | MTD | NTRA | |
| Capitalization | 22.9B | 28B | 47.9B |
| EBITDA | -411.19M | 1.3B | -227.7M |
| Gain YTD | 67.114 | 0.076 | 44.934 |
| P/E Ratio | N/A | 31.45 | N/A |
| Revenue | 1.18B | 4.13B | 2.5B |
| Total Cash | 1.05B | 51.4M | 1.09B |
| Total Debt | 1.7B | 2.11B | 240M |
GH | MTD | NTRA | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 72 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 99 Overvalued | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 70 | 100 | 18 | |
SMR RATING 1..100 | 100 | 2 | 95 | |
PRICE GROWTH RATING 1..100 | 35 | 27 | 35 | |
P/E GROWTH RATING 1..100 | 100 | 50 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NTRA's Valuation (54) in the Biotechnology industry is in the same range as GH (65) in the Medical Or Nursing Services industry, and is somewhat better than the same rating for MTD (99) in the Medical Specialties industry. This means that NTRA's stock grew similarly to GH’s and somewhat faster than MTD’s over the last 12 months.
NTRA's Profit vs Risk Rating (18) in the Biotechnology industry is somewhat better than the same rating for GH (70) in the Medical Or Nursing Services industry, and is significantly better than the same rating for MTD (100) in the Medical Specialties industry. This means that NTRA's stock grew somewhat faster than GH’s and significantly faster than MTD’s over the last 12 months.
MTD's SMR Rating (2) in the Medical Specialties industry is significantly better than the same rating for NTRA (95) in the Biotechnology industry, and is significantly better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that MTD's stock grew significantly faster than NTRA’s and significantly faster than GH’s over the last 12 months.
MTD's Price Growth Rating (27) in the Medical Specialties industry is in the same range as NTRA (35) in the Biotechnology industry, and is in the same range as GH (35) in the Medical Or Nursing Services industry. This means that MTD's stock grew similarly to NTRA’s and similarly to GH’s over the last 12 months.
MTD's P/E Growth Rating (50) in the Medical Specialties industry is somewhat better than the same rating for NTRA (100) in the Biotechnology industry, and is somewhat better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that MTD's stock grew somewhat faster than NTRA’s and somewhat faster than GH’s over the last 12 months.
| GH | MTD | NTRA | |
|---|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 75% | 3 days ago 59% |
| Stochastic ODDS (%) | 3 days ago 78% | 3 days ago 67% | 3 days ago 72% |
| Momentum ODDS (%) | 3 days ago 78% | 3 days ago 61% | 3 days ago 85% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 75% | 3 days ago 85% |
| TrendWeek ODDS (%) | 3 days ago 80% | 3 days ago 64% | 3 days ago 81% |
| TrendMonth ODDS (%) | 3 days ago 84% | 3 days ago 60% | 3 days ago 81% |
| Advances ODDS (%) | 3 days ago 82% | 12 days ago 60% | 20 days ago 80% |
| Declines ODDS (%) | 10 days ago 85% | 6 days ago 66% | 10 days ago 77% |
| BollingerBands ODDS (%) | N/A | 3 days ago 74% | 3 days ago 82% |
| Aroon ODDS (%) | N/A | 3 days ago 59% | 3 days ago 83% |
Advertisement
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | +0.14% | ||
| A - MTD | 68% Closely correlated | +1.73% | ||
| BRKR - MTD | 67% Closely correlated | -0.60% | ||
| TMO - MTD | 65% Loosely correlated | +0.27% | ||
| AZTA - MTD | 61% Loosely correlated | +2.44% | ||
| RVTY - MTD | 59% Loosely correlated | +0.50% | ||
More | ||||
NTRA and
Correlation & Price change
A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ISRG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To NTRA | 1D Price Change % | ||
|---|---|---|---|---|
| NTRA | 100% | +2.21% | ||
| ISRG - NTRA | 53% Loosely correlated | +1.16% | ||
| ADPT - NTRA | 51% Loosely correlated | +2.16% | ||
| GH - NTRA | 49% Loosely correlated | +1.67% | ||
| NEO - NTRA | 48% Loosely correlated | +2.72% | ||
| PSNL - NTRA | 48% Loosely correlated | +8.89% | ||
More | ||||